Trial
NCT02168725
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors
Phase ITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Traws Pharma, Inc.
Collaborators
—
Condition
Neoplasms
Intervention
briciclib
Why stopped
The study was placed on hold by the FDA due to manufacturing issues and was not restarted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-22